Tumor cell macrophages with an M2 phenotype produce high levels of active TGF-β, aiding the conversion of CD4 T cells into suppressive Tregs, which ultimately promotes TGF-β-driven EMT and immune evasion. The gene discussed is TGFB1; the disease is neoplasm.